Teladoc catalysts give reason to own stock now, says Jefferies

Jefferies analyst Sean Dodge says his firm’s updated market share analysis continues to show Teladoc as the dominant vendor. SimilarWeb data points to BetterHelp usage down quarter-over-quarter in November but stabilizing in December and up in January, Dodge tells investors in a research note. There are “multiple upcoming catalysts, giving investors a reason to own the stock now,” says the analyst. He points out Teladoc shares are still down over 30% from their late-September highs. Dodge keeps a Buy rating on the stock with a $95 price target, which represents 57% upside potential.
https://thefly.com/landingPageNews.php?id=2850275